These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 9481601)
1. Treatment with CL 316,243, a beta 3-adrenoceptor agonist, reduces serum leptin in rats with diet- or aging-associated obesity, but not in Zucker rats with genetic (fa/fa) obesity. Ghorbani M; Himms-Hagen J Int J Obes Relat Metab Disord; 1998 Jan; 22(1):63-5. PubMed ID: 9481601 [TBL] [Abstract][Full Text] [Related]
2. Appearance of brown adipocytes in white adipose tissue during CL 316,243-induced reversal of obesity and diabetes in Zucker fa/fa rats. Ghorbani M; Himms-Hagen J Int J Obes Relat Metab Disord; 1997 Jun; 21(6):465-75. PubMed ID: 9192230 [TBL] [Abstract][Full Text] [Related]
3. Bromocriptine administration reduces hyperphagia and adiposity and differentially affects dopamine D2 receptor and transporter binding in leptin-receptor-deficient Zucker rats and rats with diet-induced obesity. Davis LM; Michaelides M; Cheskin LJ; Moran TH; Aja S; Watkins PA; Pei Z; Contoreggi C; McCullough K; Hope B; Wang GJ; Volkow ND; Thanos PK Neuroendocrinology; 2009; 89(2):152-62. PubMed ID: 18984941 [TBL] [Abstract][Full Text] [Related]
4. Hypertrophy of brown adipocytes in brown and white adipose tissues and reversal of diet-induced obesity in rats treated with a beta3-adrenoceptor agonist. Ghorbani M; Claus TH; Himms-Hagen J Biochem Pharmacol; 1997 Jul; 54(1):121-31. PubMed ID: 9296358 [TBL] [Abstract][Full Text] [Related]
5. Improvement of metabolic disorders and visceral fat obesity by the beta 3-adrenoceptor agonist (R*,R*)-(+/-)-methyl-4-[2-[2-hydroxy-2 -(3-chlorophenyl)ethylamino]propyl]-phenoxyacetate hydrobromide (BRL35135A) in genetically obese rodents. Hashimoto K; Nagao Y; Ida K; Takeda M; Murakami N; Kato K; Mizota M Biochem Pharmacol; 1996 Nov; 52(10):1529-35. PubMed ID: 8937467 [TBL] [Abstract][Full Text] [Related]
6. Apparent histological changes of adipocytes after treatment with CL 316,243, a β-3-adrenergic receptor agonist. Ghorbani M; Teimourian S; Farzad R; Asl NN Drug Des Devel Ther; 2015; 9():669-76. PubMed ID: 25709398 [TBL] [Abstract][Full Text] [Related]
7. Anti-obesity and anti-diabetic effects of CL316,243, a highly specific beta 3-adrenoceptor agonist, in Otsuka Long-Evans Tokushima Fatty rats: induction of uncoupling protein and activation of glucose transporter 4 in white fat. Umekawa T; Yoshida T; Sakane N; Saito M; Kumamoto K; Kondo M Eur J Endocrinol; 1997 Apr; 136(4):429-37. PubMed ID: 9150705 [TBL] [Abstract][Full Text] [Related]
8. Impaired beta-adrenergic signaling pathway in white adipocytes of suckling fa/fa Zucker rats: a defect in receptor coupling. Mory G; Wiel M; Adli H; Diot-Dupuy F; Ferré P; Bazin R Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1592-8. PubMed ID: 11753576 [TBL] [Abstract][Full Text] [Related]
9. Effects of pioglitazone on promoting energy storage, not expenditure, in brown adipose tissue of obese fa/fa Zucker rats: comparison to CL 316,243. Burkey BF; Dong M; Gagen K; Eckhardt M; Dragonas N; Chen W; Grosenstein P; Argentieri G; de Souza CJ Metabolism; 2000 Oct; 49(10):1301-8. PubMed ID: 11079820 [TBL] [Abstract][Full Text] [Related]
10. Central exendin-4 infusion reduces body weight without altering plasma leptin in (fa/fa) Zucker rats. Al-Barazanji KA; Arch JR; Buckingham RE; Tadayyon M Obes Res; 2000 Jul; 8(4):317-23. PubMed ID: 10933308 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker-ZDF rats. Liu X; Pérusse F; Bukowiecki LJ Am J Physiol; 1998 May; 274(5):R1212-9. PubMed ID: 9644032 [TBL] [Abstract][Full Text] [Related]
12. Effect of a beta-3 agonist on food intake in two strains of rats that differ in susceptibility to obesity. White CL; Ishihara Y; Dotson TL; Hughes DA; Bray GA; York DA Physiol Behav; 2004 Sep; 82(2-3):489-96. PubMed ID: 15276814 [TBL] [Abstract][Full Text] [Related]
13. Leptin-induced lipolysis opposes the tonic inhibition of endogenous adenosine in white adipocytes. Frühbeck G; Gómez-Ambrosi J; Salvador J FASEB J; 2001 Feb; 15(2):333-40. PubMed ID: 11156949 [TBL] [Abstract][Full Text] [Related]
14. Differential regulation of uncoupling proteins by chronic treatments with beta 3-adrenergic agonist BRL 35135 and metformin in obese fa/fa Zucker rats. Savontaus E; Rouru J; Boss O; Huupponen R; Koulu M Biochem Biophys Res Commun; 1998 May; 246(3):899-904. PubMed ID: 9618309 [TBL] [Abstract][Full Text] [Related]
15. Insulin induces rapid changes of plasma leptin in lean but not in genetically obese (fa/fa) rats. Pagano C; Englaro P; Granzotto M; Blum WF; Sagrillo E; Ferretti E; Federspil G; Vettor R Int J Obes Relat Metab Disord; 1997 Jul; 21(7):614-8. PubMed ID: 9226494 [TBL] [Abstract][Full Text] [Related]
16. Leptin production by the stomach is up-regulated in obese (fa/fa) Zucker rats. Picó C; Sánchez J; Oliver P; Palou A Obes Res; 2002 Sep; 10(9):932-8. PubMed ID: 12226142 [TBL] [Abstract][Full Text] [Related]
18. Leptin resistance before and after obesity: evidence that tissue glucose uptake underlies adipocyte enlargement and liver steatosis/steatohepatitis in Zucker rats from early-life stages. Guzzardi MA; Guiducci L; Campani D; La Rosa F; Cacciato Insilla A; Bartoli A; Cabiati M; De Sena V; Del Ry S; Burchielli S; Bonino F; Iozzo P Int J Obes (Lond); 2022 Jan; 46(1):50-58. PubMed ID: 34489524 [TBL] [Abstract][Full Text] [Related]
19. Acute injection of beta-adrenoceptor agonist BRL 35135 corrects both impaired uncoupling protein and lipoprotein lipase gene expression but not hypercapacity of lipogenesis in brown adipose tissue of suckling fa/fa rats. Marie V; Dupuy F; Bazin R Int J Obes Relat Metab Disord; 1994 May; 18(5):273-9. PubMed ID: 7914794 [TBL] [Abstract][Full Text] [Related]
20. Lowering plasma free fatty acids with Acipimox mimics the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker diabetic fatty rats. Blachère JC; Pérusse F; Bukowiecki LJ Metabolism; 2001 Aug; 50(8):945-51. PubMed ID: 11474483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]